Ham, A.; Lee, Y.; Kim, H.S.; Lim, T.
Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer. Cancers 2023, 15, 4198.
https://doi.org/10.3390/cancers15164198
AMA Style
Ham A, Lee Y, Kim HS, Lim T.
Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer. Cancers. 2023; 15(16):4198.
https://doi.org/10.3390/cancers15164198
Chicago/Turabian Style
Ham, Ahrong, Young Lee, Hae Su Kim, and Taekyu Lim.
2023. "Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer" Cancers 15, no. 16: 4198.
https://doi.org/10.3390/cancers15164198
APA Style
Ham, A., Lee, Y., Kim, H. S., & Lim, T.
(2023). Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer. Cancers, 15(16), 4198.
https://doi.org/10.3390/cancers15164198